RAC 7.61% $1.70 race oncology ltd

RAC - Charts & Price Action, page-235

  1. 2,618 Posts.
    lightbulb Created with Sketch. 9965
    I forgot to directly answer your question and no the FDA can’t just take our patents and give them to COH. There is only one rational path forward for the COH if they want to see bisantrene being used in the clinic.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.